Plasma‐based proteomic analysis identifies distinct molecular subtypes of Alzheimer's disease pathogenesis

Abstract

Background: Alzheimer's disease (AD) is characterized by significant molecular heterogeneity. Plasma proteomics offers an opportunity to identify novel biomarkers and understand disease mechanisms. Further classification by amyloid and tau profile allows us to focus on distinct AD pathophysiology.

The paper